Skip to main content

and
  1. Article

    Open Access

    Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract

    As a result of the high approval dynamics and the growing number of immuno-oncological concepts, the complexity of treatment decisions and control in the area of cancers of the esophagus, gastroesophageal junc...

    Gustavo B. Baretton, Florian Lordick in Journal of Cancer Research and Clinical On… (2023)

  2. Article

    Open Access

    The OUTREACH study: oncologists of German university hospitals in rotation on a palliative care unit—evaluation of attitude and competence in palliative care and hospice

    The effect of the duration of an educational rotation presented at a palliative care unit on the palliative care knowledge gain and the increase of palliative care self-efficacy expectations are unclear.

    T. Biersching, A. Schweda, K. Oechsle in Journal of Cancer Research and Clinical On… (2023)

  3. No Access

    Chapter

    Palliative Chemotherapie: Standard und Individualisierung des Magen- und Kardiakarzinoms

    Bei dem überwiegenden Anteil der Patienten mit Magenkarzinom wird die Erkrankung erst in einem Stadium diagnostiziert, in dem eine kurative Operation nicht mehr in Frage kommt. Solchen Patienten sollte man ein...

    P. Thuss-Patience in Moderne Chirurgie des Magen- und Kardiakarzinoms (2017)

  4. No Access

    Article

    Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab—monitoring of antiphospholipid and anti-GP antibodies: a case report

    R. Trappe, A. Loew, P. Thuss-Patience, B. Dörken, H. Riess in Annals of Hematology (2006)

  5. Article

    Open Access

    Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial

    To assess the response rate and the tolerance of irinotecan as first-line therapy, 40 patients with metastatic gastric cancer received irinotecan 350 mg m−2 every 3 weeks administered as a 30 min infusion. Among ...

    C-H Köhne, R Catane, B Klein, M Ducreux, P Thuss-Patience in British Journal of Cancer (2003)

  6. No Access

    Article

    Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity

    Two patients with proven 5-fluorouracil (5-FU)-associated cardiotoxicity were treated with the specific thymidylate synthase inhibitor raltitrexed safely, without evidence of cardiotoxicity. Raltitrexed might ...

    C-H Köhne, P Thuss-Patience, M Friedrich, PT Daniel in British Journal of Cancer (1998)